Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential.

Journal: Frontiers in cellular neuroscience

Volume: 18

Issue: 

Year of Publication: 

Affiliated Institutions:  Fungal and Parasitic Molecular Biology Laboratory LR ES, Faculty of Medicine, University of Sfax, Sfax, Tunisia. Psychiatry "B" Department, Hedi Chaker University Hospital, Sfax, Tunisia. Genomics of Signalopathies at the Service of Precision Medicine LRES FMS, University of Sfax, Sfax, Tunisia. Department of Pneumology, Faculty of Medicine, University of Sfax, Sfax, Tunisia. Reserach Unit "Drosophila"URES, Faculty of Medicine, University of Sfax, Sfax, Tunisia. Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.

Abstract summary 

The human gut mycobiome, a minor but integral component of the gut microbiome, has emerged as a significant player in host homeostasis and disease development. While bacteria have traditionally been the focus of gut microbiome studies, recent evidence suggests that fungal communities (mycobiota) may also play a crucial role in modulating health, particularly in neuropsychiatric disorders.This review aims to provide a comprehensive overview of current knowledge on the relationship between the gut mycobiome and neuropsychiatric disorders, exploring the potential of targeting fungal communities as a novel therapeutic strategy.We summarized recent findings from metagenomic analyses that characterize the diversity and composition of gut mycobiota and discuss how these communities interact with the host and other microorganisms via the gut-brain axis. Key methodologies for studying mycobiota, such as high-throughout sequencing and bioinformatics approaches, were also reviewed to highlight advances in the field.Emerging research links gut mycobiota dysbiosis to conditions such as schizophrenia, Alzheimer's disease, autism spectrum disorders, bipolar disorder, and depression. Studies indicate that specific fungal populations, such as and , may influence neuroinflammation, gut permeability and immune responses, thereby affecting mental health outcomes.Understanding the gut mycobiome's role in neuropsychiatric disorders opens new avenues for therapeutic interventions, including antifungal treatments, probiotics, and dietary modifications. Future research should integrate multi-omics approaches to unravel the complex interkingdom interactions within the gut ecosystem, paving the way for personalized medicine in mental health care.

Authors & Co-authors:  Hadrich Ines I Turki Mariem M Chaari Imen I Abdelmoula Balkiss B Gargouri Rahma R Khemakhem Nahed N Elatoui Dhawia D Abid Fatma F Kammoun Sonda S Rekik Mona M Aloulou Samir S Sehli Mariem M Mrad Aymen Ben AB Neji Sourour S Feiguin Fabian M FM Aloulou Jihene J Abdelmoula Nouha Bouayed NB Sellami Hayet H

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Adams J. B., Johansen L. J., Powell L. D., Quig D., Rubin R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11:22. 10.1186/1471-230X-11-22
Authors :  18
Identifiers
Doi : 1495224
SSN : 1662-5102
Study Population
Male,Female
Mesh Terms
Other Terms
dysbiosis;fungi;gut mycobiome;gut-brain axis;innovative therapy;neuropsychiatric disorders
Study Design
Study Approach
Country of Study
Publication Country
Switzerland